Levcromakalim 是 一种ATP 敏感性的 K+通道 (KATP) 激活剂。
产品描述
Levcromakalim is an activator of the ATP-sensitive K+ channel.
体外活性
Levcromakalim inhibits spontaneous contractions completely in a glibenclamide-sensitive manner. LevCromakalim (5 μM) inhibits spontaneous contractions, which are recovered by glibenclamide. Levcromakalim (1, 5 and 10 μM) inhibits phasic contractions to 34±21.1%, 20.1±20.0% and 0% of the control. Glibenclamide reverses the inhibition of spontaneous isometric contractions caused by LevCromakalim (5 μM) to 84±1.5% of the control. Levcromakalim (20 and 100 μM) also inhibits oxytocin (OXT) (10 nM)-induced phasic contractions to 34±21.4% and 14±12.6% of the control [2]. LevCromakalim induces dose-dependent relaxation in both the young and old mesenteric artery (MAs); there is no difference in relaxation with age. However, the relaxation is markedly reduced in response to the high-salt (HS) diet in the old MAs (P<0.05). Maximum dilations to Levcromakalim (10-4 M) are 97 ± 3% in the young MAs versus 98 ± 1% in the young salt arteries, while dilations are 99±0.7% in the old MAs when compared with 85 ± 5% in the old salt arteries (P<0.05) [3].
Cas No.
94535-50-9
分子式
C16H18N2O3
分子量
286.33
别名
左色满卡林;BRL 38227;(-)-Cromakalim
储存和溶解度
H2O:Insoluble
DMSO:50 mg/mL (174.62 mM )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years